Thyroid nodules - thyroid dysfunction (non-suspected cancer)

exp date isn't null, but text field is

CARBIMAZOLE tablets 5mg, 20mg
Dose: 15 to 40mg daily, maintained until patient becomes euthyroid, usually after 4 to 8 weeks; the dose may then be progressively reduced to a maintenance of between 5 and 15mg daily.

See Highland Formulary: Antithyroid drugs

Treatment

Levothyroxine (T4) should be initiated once daily at a dose of 0.8 to 1.6 micrograms/kg, which is usually 50 to 125 micrograms. A lower dose should be used for elderly patients and patients with cardiac disease. It must be taken on an empty stomach, with no food consumption for 30 minutes. Not taking it in this way may prevent optimised treatment.

The aims of treatment are to manage the patient's hypothyroid symptoms and maintain thyroid stimulating hormone (TSH) levels within the normal range. If the TSH levels are too low then there is an increased risk of developing atrial fibrillation and osteoporosis. If the aims of treatment are not achieved with levothyroxine then the following should be checked:

  • Is the dose correct for the weight of the patient?
  • Is the treatment being taken correctly on an empty stomach?
  • Are there other treatments that might impair absorption (antacids, proton pump inhibitors, histamine-2-receptor antagonists)?
  • Are there other undiagnosed endocrine or auto-immune conditions?
  • Are there other causes of fatigue (depression, fibromyalgia, etc)?

These factors should be taken into account for any patient being considered for liothyronine (T3) treatment and when reviewing existing patients. Liothyronine must only be initiated by an endocrinologist. 

Further information

Further information is available from the British Thyroid Association – Management of Primary Hypothyroidism & FAQs for GPs

Editorial Information

Last reviewed: 30 November 2014

Next review: 30 November 2017

Author(s): Consultant Physician

Version: 2

Approved By: high-uhb.tam@nhs.net

Reviewer Name(s): Prof Sandra MacRury, Angus Cain

Document Id: TAM184